Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial

Japanese gastric cancer treatment guidelines 2018 (5th edition)

(2020)   Gastric Cancer

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

(2020) Alessandro Leal et al.   Nature Communications

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

(2020) Jian Yang et al.   Cell Death & Disease

Towards Personalization in the Curative Treatment of Gastric Cancer

(2020) Astrid E. Slagter et al.   Frontiers in Oncology

Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma

(2019) Rosa T. van der Kaaij et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Life and death of circulating cell-free DNA

(2019) Anatoli Kustanovich et al.   CANCER BIOLOGY & THERAPY

Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer

(2019) Tej D. Azad et al.   GASTROENTEROLOGY

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

(2018) Annemieke Cats et al.   LANCET ONCOLOGY

Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer

(2018) Tsutomu Namikawa et al.   Gastric Cancer

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

(2017) Charles S. Fuchs et al.   Journal of Gastric Cancer

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) E. C. Smyth et al.   ANNALS OF ONCOLOGY

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

(2016) Elizabeth C. Smyth et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic value of preoperative serum lactate dehydrogenase levels for resectable gastric cancer and prognostic nomograms

(2016) Zi-Xian Wang et al.   Oncotarget

Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis

(2015) Yong-xi Song et al.   DISEASE MARKERS

The Prognostic Significance of Pretreatment Serum CEA Levels in Gastric Cancer: A Meta-Analysis Including 14651 Patients

(2015) Kai Deng et al.   PLoS One

The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer

(2014) Zhi Zhao et al.   DISEASE MARKERS

Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients

(2014) Xuren Sun et al.   PLoS One

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)

(2011) Johan L Dikken et al.   BMC CANCER

A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy

(2010) D. Kanagavel et al.   ANNALS OF ONCOLOGY

Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram

(2010) Vivian E. Strong et al.   ANNALS OF SURGERY